Company research / RHEP

Regional Health Properties, Inc (RHEP)

Also trades as RHEPA, RHEPB, RHEPZ. Every security a company lists rests on one set of financial statements, so these figures cover the whole company.

SEC name REGIONAL HEALTH PROPERTIES, INC · CIK 0001004724 · OTC · Lessors of Real Property, NEC

  • Sector Finance & Real Estate
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Regional Health Properties, Inc reported revenue of $53.16M. Revenue grew 189.9% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $81.52M.

Key ratios (year ended 2025-12-31)

86.9%
Gross margin (computed)
3.1%
Operating margin
6.3%
Net margin
965.6%
Return on year-end equity
189.9%
Revenue growth (YoY)

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form DEF 14A (proxy statement) · 2026-10-02

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Stock splits: 1-for-12, first reflected in a filing dated 2019-05-17. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$81.52M$53.16M$18.34M$17.16M$35.92M$26.69M$17.58M$20.13M$22.05M$25.15M$27.60M
Cost of Revenuen/a$6.98Mn/an/an/an/an/an/an/an/an/a
Gross Profit (computed)n/a$46.18Mn/an/an/an/an/an/an/an/an/a
Operating Income$1.57M$1.66M$161.0K-$821.0K-$6.82M$2.53M$2.29M$5.46M-$792.0K$5.14M$4.52M
Depreciation & Amortization$2.74M$2.06M$2.06M$2.25M$2.40M$2.59M$2.89M$3.44M$4.63M$4.87M$5.30M
EBITDA$4.31M$3.73M$2.22M$1.43M-$4.42M$5.12M$5.19M$8.90M$3.84M$10.01M$9.81M
Net Income$4.07M$3.37M-$3.22M-$3.89M-$6.87M-$1.18M-$688.0K$5.50M-$11.89M-$985.0K-$7.46M
EPS (Diluted)n/a$1.09-$1.73$21.05-$8.93-$5.87n/an/an/an/a-$0.74
Total Assets$67.96M$67.81M$60.47M$62.18M$68.58M$105.70M$108.03M$113.76M$100.57M$106.55M$119.49M
Total Liabilities$64.98M$62.77M$63.38M$62.00M$64.86M$95.30M$96.92M$102.02M$94.42M$88.68M$95.99M
Long-Term Debt$42.56M$43.15M$49.72M$50.73M$52.18M$52.88M$54.44M$55.36M$81.31M$73.10M$79.97M
Shareholders' Equity-$1.71M$349.0K-$2.92M$185.0K$3.72M$10.40M$11.10M$11.74M$6.15M$17.87M-$37.95M
Cash & Equivalents$1.70M$3.00M$582.0K$1.00M$800.0K$6.80M$4.20M$4.40M$2.40M$1.82M$14.04M
Operating Cash Flow-$2.57M-$2.26M$1.94M$3.71M-$3.60M$4.89M$1.29M$2.40M$1.35M$5.14M-$3.41M
Capital Expenditures$1.37M$869.0K$530.0K$958.0K$281.0K$123.0K$450.0K$58.0K$338.0K$846.0K$1.50M
Free Cash Flow-$3.94M-$3.13M$1.41M$2.75M-$3.88M$4.77M$845.0K$2.34M$1.01M$4.30M-$4.91M
Share Repurchasesn/an/an/an/a$46.0K$7.0Kn/an/an/a$186.0K$523.0K
Dividends Paidn/an/an/an/an/an/an/an/an/an/a$0
Shares Outstanding3.92M3.93M1.88Mn/a1.78M1.77M1.69M1.69M1.69M1.65M19.93M
Dividends Per Sharen/an/an/an/an/an/an/an/an/an/a$0.17
Weighted Average Diluted Sharesn/an/an/a1.9K1.78M1.73Mn/an/an/an/a19.89M
EPS (Basic)n/a$1.09-$1.73$21.05-$8.93-$5.87n/an/an/an/a-$0.74